Latent membrane protein 1: a key oncogene in EBV-related carcinogenesis?

Acta Haematol. 1993;90(4):167-71. doi: 10.1159/000204451.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigens, Viral / chemistry
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology*
  • Burkitt Lymphoma / etiology*
  • Burkitt Lymphoma / genetics
  • Burkitt Lymphoma / immunology
  • Gene Deletion
  • Gene Expression Regulation, Viral / genetics
  • Gene Expression Regulation, Viral / immunology
  • Herpesviridae Infections / etiology*
  • Herpesviridae Infections / genetics
  • Herpesviridae Infections / immunology
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / immunology*
  • Herpesvirus 4, Human / pathogenicity
  • Humans
  • Molecular Structure
  • Oncogenes* / genetics
  • Oncogenes* / immunology
  • Tumor Cells, Cultured
  • Tumor Virus Infections / etiology*
  • Tumor Virus Infections / genetics
  • Tumor Virus Infections / immunology
  • Viral Matrix Proteins / chemistry
  • Viral Matrix Proteins / genetics
  • Viral Matrix Proteins / immunology*

Substances

  • Antigens, Viral
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins